CompoAtlas

Phyto Phenols

Natural health product licensed in Canada

Licence holder
Cyto-Matrix Inc.
NPN or DIN-HM
80018573
Status
Inactive licence
Licence date
11 May 2010
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
phytostérols

Source : Huile de fève de soja

Potency : 41 % Beta-sitosterol

200 mgNot calculated
phytostérols

Source : Huile de fève de soja

Potency : 22 % Campesterol

Not specifiedNot calculated
phytostérols

Source : Huile de fève de soja

Potency : 28 % Stigmasterol

Not specifiedNot calculated

Non-medicinal ingredients

Microcrystalline cellulose, Hypromellose, Glycine max soy (fibre)

PopulationAgeQuantity per servingFrequency
AdultesNot specified4 Capsule3 Tous les jours
AdultesNot specified1 Capsule2 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Used in the management of hyperlipidemia. Helps relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80018573

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line